Improving Clinical Execution & Translational Rigor to Unlock Success in Atopic Dermatitis and Alopecia Trials
- Key learnings from a 400-patient blinded trial highlight the importance of early patient selection precision and site training quality
- Bridging systemic and local biomarkers through longitudinal sampling to understand dynamic disease resolution beyond static endpoints
- Enhancing trial design by capturing real-time lesion evolution using intensive clinical sampling during active disease
- Strengthening translational frameworks to better connect molecular change with clinically meaningful improvement in dermatologic endpoints